Fig. 7From: HOXA13 promotes gastric cancer progression partially via the FN1-mediated FAK/Src axisDirect binding of HOXA13 to the FN1 promoter region. a Six possible HBSs located at different sites in the FN1 promoter region. b Dual luciferase assay was conducted to examine FN1 promoter activity. c ChIP assays were performed with a specific anti-Flag antibody or IgG to determine the binding sites (**p < 0.01, ***p < 0.001, #p > 0.05)Back to article page